Jul 29, 2026 – 5.00pmAmsterdam-based medical technology company Nicolab is passing the hat around for $6 million to support its long-running goal of an ASX listing next year.Investors and readers of this column would be well-versed in the stroke treatment provider’s multiple earlier attempts to list – dating back to 2018. Its flagship product is a cloud-native stroke diagnostics and triage platform dubbed StrokeViewer.Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones.Kanika Sood is a journalist based in Sydney who writes for the Street Talk column.Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review.Angira Bharadwaj is a co-editor of Street Talk. She covers IPOs, capital raises, mergers and acquisitions and other breaking news in Australia’s capital markets. Previously, she covered financial services, state, and federal politics. Send tips to @angirab.60 on encrypted messaging platform Signal.Subscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber?
Third time lucky? Medtech Nicolab targets ASX float with pre-IPO raise
Street Talk has canvassed Amsterdam-based Nicolab’s attempts at an IPO since 2018.
198 words~1 min read
